Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
PLAYSTUDIOS A | MYPS | Sep 19, 2024 | 1.50 | -8.54 |
Playtika Holding | PLTK | Sep 19, 2024 | 8.19 | +3.80 |
PLBY Group | PLBY | Sep 19, 2024 | 0.77 | +2.22 |
PLDT ADR | PHI | Sep 19, 2024 | 26.24 | -0.08 |
Plexus | PLXS | Sep 19, 2024 | 132.39 | +3.43 |
Pliant Therapeutics | PLRX | Sep 19, 2024 | 12.62 | +0.96 |
Plug Power | PLUG | Sep 19, 2024 | 2.06 | -1.90 |
Plum Acquisition I A | PLMI | Sep 19, 2024 | 9.00 | 0.00 |
Plum Acquisition I Units | PLMIU | Sep 19, 2024 | 10.89 | 0.00 |
Plum Acquisition III A | PLMJ | Sep 19, 2024 | 10.85 | 0.00 |
Plum Acquisition III Unit | PLMJU | Sep 19, 2024 | 10.71 | 0.00 |
Plumas Bancorp | PLBC | Sep 19, 2024 | 43.33 | +4.08 |
Pluri | PLUR | Sep 19, 2024 | 5.47 | +5.19 |
Plus Therapeutics | PSTV | Sep 19, 2024 | 1.60 | -1.23 |
Plymouth Industrial Reit | PLYM | Sep 19, 2024 | 23.27 | +1.26 |
PMV Pharmaceuticals | PMVP | Sep 19, 2024 | 1.52 | +0.66 |
PNC Financial Services Group | PNC | Sep 19, 2024 | 187.20 | +2.54 |
PodcastOne | PODC | Sep 19, 2024 | 1.82 | +7.69 |
POET Technologies | POET | Sep 19, 2024 | 3.14 | +2.95 |
Poland Investable Mkt Index MSCI Ishares | EPOL | Sep 19, 2024 | 24.45 | +1.79 |
Polar Power | POLA | Sep 19, 2024 | 0.42 | +1.29 |
Polaris | PII | Sep 19, 2024 | 85.86 | +2.85 |
Polestar ADR | PSNY | Sep 19, 2024 | 1.61 | -1.23 |
PolyPid | PYPD | Sep 19, 2024 | 3.46 | +0.29 |
Ponce Financial Group | PDLB | Sep 19, 2024 | 11.86 | +2.95 |
Pono Capital Two SPAC A | PTWO | Sep 19, 2024 | 11.00 | 0.00 |
Pool | POOL | Sep 19, 2024 | 372.09 | +0.86 |
Pop Culture Group A | CPOP | Sep 19, 2024 | 1.15 | +4.55 |
Popular | BPOP | Sep 19, 2024 | 102.13 | +2.46 |
Popular Popular Capital Trust II | BPOPM | Sep 19, 2024 | 26.00 | -0.27 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.